SCHEMBL6444641

SCHEMBL6444641

CC(C)C(CC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1cccnc1)C(C)C

nearest known ligand 0.51

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CTSD P07339 3/20 0.51
CYP3A4 P08684 3/20 0.46
BACE1 P56817 2/20 0.46
REN P00797 1/20 0.45
KLK5 Q9Y337 1/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CA2 P00918 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6446462 0.90 CTSD (0.56) CTSDCYP3A4BACE1KLK5
SCHEMBL6446319 0.88 CTSD (0.63) CTSDCYP3A4RENCTSLCTSB
SCHEMBL6448343 0.88 CTSD (0.63) CTSDCYP3A4RENCTSLCTSB
SCHEMBL6449478 0.88 CTSD (0.63) CTSDCYP3A4RENCTSLCTSB
Trifluoroacetic Acid SCHEMBL6448506 0.88 CTSD (0.52) CTSDCYP3A4RENCTSLCTSB
SCHEMBL7268971 0.86 CTSD (0.63) CTSDCYP3A4RENCTSLCTSB
SCHEMBL7275770 0.85 CTSD (0.65) CTSDCYP3A4RENCTSLCTSB
SCHEMBL6447685 0.83 CTSD (0.57) CTSDCYP3A4RENCTSLCTSB
SCHEMBL6448499 0.82 CTSD (0.48) CTSDCYP3A4RENCTSLCTSB
SCHEMBL15095216 0.82 CTSD (0.67) CTSDBACE1KLK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed